ATRA (atarabio.com) Sof foyda

ATRA (atarabio.com) - kompaniyaning tovar belgisi

Atara Biotherapeutics (ATRA) kuchli patent himoyasi tufayli skleroz terapiyasi sohasidagi o'z mavqeini saqlab qolmoqda. Kompaniya transplantatsiyadan keyingi asoratlarni davolash uchun Ebvallo tizimini ishlab chiqmoqda, bu esa yopiq terapevtik siklni yaratadi. Biroq, biotexnologiya gigantlarining shiddatli raqobati xatarlarni oshiradi. Ushbu grafikdagi kompaniyaning joriy foydasi tushumlar dinamikasini aks ettiradi, bunda -0.02 ko'rsatkichning joriy qiymatini belgilaydi.

ATRA (Atara Biotherapeutics) Sof foyda tarixi 04.07.2022dan 29.10.2026gacha

atarabio.com (ATRA) kompaniyasining tahliliy kesimlari va maʼlumotlar hisoboti

- narx va narxlar bo'yicha konsensus prognoz:
Aksiya kotirovkalari Atara Bio|ATRA - Tahlilchilar konsensus prognozi
- biznesning bozor baholash ko'rsatkichlari:
Bozor kapitallashuvi ATRA|ATRA - Kompaniyani butunlay sotib olishdagi haqiqiy narx
- balans kapitallashuvi bo'yicha ma'lumotlar:
Aksiyaning buxgalteriya qiymati Atara Biotherapeutics|ATRA - Balans kapitallashuvi|Balans qiymatiga nisbatan bozor kapitallashuvi atarabio.com|ATRA - Kompaniyaning jami aktivlari
- qarzlar va to'lov qobiliyati haqida ma'lumot:
Umumiy qarzning xususiy kapitalga nisbati Atara Biotherapeutics|ATRA - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning o'z kapitaliga nisbati Atara Bio|ATRA - Kompaniyaning umumiy qarzi|Balans kapitallashuviga qarzlar ATRA|ATRA - Kompaniyaning uzoq muddatli qarzi|Kompaniyaning qisqa muddatli qarzdorligi Atara Biotherapeutics|Shoshilinch likvidlik atarabio.com
- sof daromad va qiymat multiplikatorlari ko'rsatkichlari:
ATRA - Sof foyda
Kompaniyaning jamlanma tahlili:Atara Biotherapeutics
Atara Biotherapeutics, Inc. asosiy tovari

Hissalar aktivlarining investitsiya ishonchliligini baholash, barcha xarajatlar ayirib tashlangan sof moliyaviy natijani tahlil qilish orqali real daromadlarni bozor shovqinlaridan ajratishni talab qiladi. Ushbu moliyaviy samaradorlik ko'rsatkichi bio-chiqindilar uchun ESG optimallashtirish xarajatlarini hisobga olgan holda, hujayra texnologiyalarini monetizatsiya qilish samaradorligini aks ettiradi va investorlarga ushbu grafik orqali Atara Biotherapeutics (ATRA) biznes modelining barqarorligini aniqlash imkonini beradi.

Asosiy raqobatchilar

Sof daromad argenx BVBA|BNTX (BioNTech SE) - Sof foyda|Sof foyda Abivax Pharma|Sof daromad ADMA (ADMA Biologics, Inc.)|PTGX (Protagonist Therapeutics, Inc.) - Yakuniy foyda|Sof foyda IMVT (Immunovant Corp)|Sof moliyaviy natija Kiniksa Corp (KNSA)|GRFS - Kompaniyaning sof foydasi|adaptivebiotech.com (ADPT) - Sof daromad|Celldex Therapeutics, Inc. (CLDX) - Kompaniyaning sof foydasi|Sof daromad Aurinia Pharmaceuticals Inc|Sof daromad BCRX|Sof foyda Vera Corp|Kompaniyaning sof foydasi Dianthus Therapeutics (DNTH)|pharvaris.com - Kompaniya foydasi|Sof foyda ABCL (AbCellera Biologics Inc)|Tourmaline Bio Inc (TRML) - Kompaniyaning sof daromadi|Intrexon - Sof foyda|PHAR - Sof foyda|NKTR (Nektar Therapeutics) - Sof daromad|UPB: Soliqlar to‘langandan keyingi foyda|ZBIO (Zenas Biopharma) - Sof foyda|Sof foyda Immunome Inc|Kompaniyaning sof foydasi Gossamer Corp (GOSS)|KALV (KalVista Corp) - Yakuniy foyda|Sof foyda SEPN (Septerna Inc)|Sof foyda pieris.com PVLA|SVRA: Sof daromad|Yakuniy foyda RIGL (Rigel Pharma)|ANAB: Sof foyda|ATXS (Astria Corp) - Kompaniyaning sof foydasi|ENGN (enGene Holdings Inc.) - Sof foyda|rapt.com (RAPT) - Sof moliyaviy natija|Kompaniyaning sof foydasi Aerovate Therapeutics Inc (JBIO)|ACRS - Kompaniyaning sof daromadi|Kyverna - Sof daromad|Soliqlar to‘langandan keyingi foyda TLSA (Tiziana Life Sciences, Ltd.)|Cabaletta Bio, Inc. - Sof foyda|Yakuniy foyda VTYX (ventyxbio.com)|THTX: Sof foyda|Kompaniyaning sof daromadi Avalo Therapeutics, Inc. (AVTX)|Kompaniyaning sof foydasi Eledon|AGEN: Yakuniy foyda|Sof foyda CLYM|Sof foyda zurabio.com (ZURA)|Kompaniyaning sof foydasi aTyr Pharma ATYR|ADAG (Adagene Inc) - Soliqdan keyingi foyda|Ikena Oncology, Inc. - Sof foyda|Kompaniyaning sof daromadi Shattuck Labs, Inc.|EQ (equilliumbio.com) - Sof daromad|Connect Biopharma Holdings Limited (CNTB) - Sof foyda|Sof daromad IMUX|IFRX (InflaRx GmbH) - Soliqlar to‘langandan keyingi foyda|Sof foyda XFOR|Sof moliyaviy natija adicetbio.com|Sof foyda CELU (Celularity)|INMB - Sof daromad|BRNS - Kompaniyaning sof foydasi|Sof moliyaviy natija Kezar Life Sciences Inc. KZR|SABS: Sof foyda|Akari Therapeutics, Plc (AKTX) - Sof foyda|Sof daromad ENLV|QTTB (Q32 Bio Corp) - Soliqlar to‘langandan keyingi foyda|Kompaniyaning sof foydasi GeoVax (GOVX)|EDSA (Edesa Biotech Inc) - Yakuniy foyda|Sof foyda IBIO (iBio Corp)|Sof foyda Carisma Therapeutics Inc CARM|XTLB - Kompaniyaning sof foydasi|Soliqdan keyingi foyda BOLT|HCWB: Sof foyda|Aptevo Therapeutics Inc. - Yakuniy foyda|AIM (AIM ImmunoTech) - Sof foyda|Sof foyda Aditxt Corp|Kompaniyaning sof foydasi GRI Bio, Inc. (GRI)|XRTX (xortx.com) - Yakuniy foyda|Kompaniyaning sof foydasi Vyome Holdings HIND|REVB - Sof daromad|Indaptus - Sof foyda|SCNI - Sof foyda|CALI (calcimedica.com) - Sof daromad|Affimed N.V. - Yakuniy foyda|ALLK (Allakos Inc) - Sof foyda|HOOKIPA (HOOK) - Sof moliyaviy natija|Kompaniyaning sof foydasi IGM Biosciences, Inc. (IGMS)|Sof daromad iTeos Pharma ITOS|Kompaniyaning sof foydasi Ocean Biomedical, Inc. OCEA|TCBP - Sof daromad|THRD: Sof daromad